GPC-3 targeted hydrophilic peptides for PET imaging of hepatocellular carcinoma

被引：0
|
作者：
Wu, Hubing [1 ,2 ]
Liu, Mei [2 ]
Wang, Xiaohui [2 ]
Sun, Muchuan [2 ]
Conti, Peter [2 ]
Chen, Kai [2 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Dept Nucl Med, Guangzhou, Guangdong, Peoples R China
[2] Univ Southern Calif, Dept Radiol, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
934
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma
    Li, Youcai
    Zhang, Jun
    Gu, Jiamei
    Hu, Kongzhen
    Huang, Shun
    Conti, Peter S.
    Wu, Hubing
    Chen, Kai
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (01) : 134 - 143
  • [2] Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma
    Youcai Li
    Jun Zhang
    Jiamei Gu
    Kongzhen Hu
    Shun Huang
    Peter S. Conti
    Hubing Wu
    Kai Chen
    Molecular Imaging and Biology, 2020, 22 : 134 - 143
  • [3] GPC-3 in hepatocellular carcinoma: current perspectives
    Wu, Yongle
    Liu, Hui
    Ding, Huiguo
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2016, 3 : 63 - 67
  • [4] Novel GPC-3 Targeted Therapies Require Hepatocellular Carcinoma Tissue Evaluation for GPC-3 Status: A Plea to Reinstitute Biopsy Procurement After Diagnostic Multiphase Imaging
    Sivanandham, Sindhuja
    Jakate, Shriram
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1157 - 1157
  • [5] Novel GPC-3 Targeted Therapies Require Hepatocellular Carcinoma Tissue Evaluation for GPC-3 Status: A Plea to Reinstitute Biopsy Procurement After Diagnostic Multiphase Imaging
    Sivanandham, Sindhuja
    Jakate, Shriram
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1157 - 1157
  • [6] Preclinical evaluation of GPC3-targeting peptides for PET imaging of hepatocellular carcinoma
    Hu, Wenzhu
    Li, Mengting
    Feng, Lixia
    Lin, Zhaoguo
    Wei, Weijun
    Jiang, Dawei
    An, Rui
    Lan, Xiaoli
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [7] Gpc-3 is a Notable Diagnostic, Prognostic and a Latent Targeted Therapy Marker in Hepatocellular Carcinoma
    Zou, Zhi-Qiang
    Ding, Yu-Ping
    Long, Bo
    Yu, Ji-Guang
    Xu, Ai-Ling
    Lang, Zhen-Wei
    Zou, Sai-Ying
    Liu, You-De
    Ding, Kun
    Li, Yuan-Yuan
    HEPATO-GASTROENTEROLOGY, 2010, 57 (102-03) : 1285 - 1290
  • [8] GPC-3 in hepatocellular carcinoma; A novel biomarker and molecular target
    Tehrani, Hamed Azhdari
    Zangi, Masood
    Fathi, Mobina
    Vakili, Kimia
    Hassan, Moustapha
    Rismani, Elham
    Hossein-Khannazer, Nikoo
    Vosough, Massoud
    EXPERIMENTAL CELL RESEARCH, 2025, 444 (02)
  • [9] Simultaneous Measurements of Serum AFP; GPC-3 and HCCR for Diagnosing Hepatocellular Carcinoma
    Qiao, Shi-Shi
    Cui, Zhu-Qing-Qing
    Gong, Lei
    Han, Hui
    Chen, Peng-Cheng
    Guo, Li-Min
    Yu, Xin
    Wei, Yu-Hua
    Ha, Seon-Ah
    Kim, Jin Woo
    Jin, Zhong-Tian
    Li, Shu
    Peng, Ji-Run
    Leng, Xi-Sheng
    HEPATO-GASTROENTEROLOGY, 2011, 58 (110) : 1718 - 1724
  • [10] PET imaging of GPC3 expression in hepatocellular carcinoma using new 18F-labeled binding peptides
    Li, Youcai
    Zhang, Jun
    Gu, Jiamei
    Hu, Kongzhen
    Huang, Shun
    Conti, Peter
    Wu, Hubing
    Chen, Kai
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345